Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 400

1.

Effects of two natural medicine formulations on irritable bowel syndrome symptoms: a pilot study.

Hawrelak JA, Myers SP.

J Altern Complement Med. 2010 Oct;16(10):1065-71. doi: 10.1089/acm.2009.0090.

PMID:
20954962
2.

Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit.

Houghton LA, Lea R, Agrawal A, Reilly B, Whorwell PJ.

Gastroenterology. 2006 Oct;131(4):1003-10. Erratum in: Gastroenterology. 2006 Dec;131(6):2029. Agrawal, Anvrag [corrected to Agrawal, Anurag].

PMID:
17030170
3.
4.

Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.

Evans BW, Clark WK, Moore DJ, Whorwell PJ.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD003960. Review.

PMID:
17943807
5.

Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation-predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.

Bensoussan A, Kellow JE, Bourchier SJ, Fahey P, Shim L, Malcolm A, Boyce P.

Clin Gastroenterol Hepatol. 2015 Nov;13(11):1946-54.e1. doi: 10.1016/j.cgh.2015.06.022.

PMID:
26133902
6.

Episodic nature of symptoms in irritable bowel syndrome.

Palsson OS, Baggish J, Whitehead WE.

Am J Gastroenterol. 2014 Sep;109(9):1450-60. doi: 10.1038/ajg.2014.181.

PMID:
24980882
7.
8.

Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.

Yao X, Yang YS, Cui LH, Zhao KB, Zhang ZH, Peng LH, Guo X, Sun G, Shang J, Wang WF, Feng J, Huang Q.

J Gastroenterol Hepatol. 2012 Apr;27(4):760-5. doi: 10.1111/j.1440-1746.2011.06930.x.

PMID:
21929652
9.

Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.

Ducrotte P, Dapoigny M, Bonaz B, Siproudhis L.

Aliment Pharmacol Ther. 2005 Feb 15;21(4):435-44.

10.

Further characterization of painful constipation (PC): clinical features over one year and comparison with IBS.

Drossman DA, Morris C, Hu Y, Leserman J, Dalton C, Toner B, Diamante N, Bangdiwala S.

J Clin Gastroenterol. 2008 Nov-Dec;42(10):1080-8.

PMID:
18949838
11.

Characterization of episodes of irritable bowel syndrome using ecological momentary assessment.

Weinland SR, Morris CB, Hu Y, Leserman J, Bangdiwala SI, Drossman DA.

Am J Gastroenterol. 2011 Oct;106(10):1813-20. doi: 10.1038/ajg.2011.170.

PMID:
21647206
12.

Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.

Basseri RJ, Kunkel D, Low K, Conklin JL, Pimentel M.

J Clin Gastroenterol. 2011 Oct;45(9):790-3. doi: 10.1097/MCG.0b013e3182053cea.

PMID:
21301356
13.

A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS.

Chang L, Ameen VZ, Dukes GE, McSorley DJ, Carter EG, Mayer EA.

Am J Gastroenterol. 2005 Jan;100(1):115-23.

PMID:
15654790
14.

IBS patients show frequent fluctuations between loose/watery and hard/lumpy stools: implications for treatment.

Palsson OS, Baggish JS, Turner MJ, Whitehead WE.

Am J Gastroenterol. 2012 Feb;107(2):286-95. doi: 10.1038/ajg.2011.358.

15.

Rifaximin therapy for patients with irritable bowel syndrome without constipation.

Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, Mareya SM, Shaw AL, Bortey E, Forbes WP; TARGET Study Group..

N Engl J Med. 2011 Jan 6;364(1):22-32. doi: 10.1056/NEJMoa1004409.

16.

A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator.

Drossman DA, Morris CB, Hu Y, Toner BB, Diamant N, Leserman J, Shetzline M, Dalton C, Bangdiwala SI.

Gastroenterology. 2005 Mar;128(3):580-9.

PMID:
15765393
17.

Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype.

Mearin F, Balboa A, Badía X, Baró E, Caldwell E, Cucala M, Díaz-Rubio M, Fueyo A, Ponce J, Roset M, Talley NJ.

Eur J Gastroenterol Hepatol. 2003 Feb;15(2):165-72.

PMID:
12560761
18.

Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome.

Tillisch K, Labus JS, Naliboff BD, Bolus R, Shetzline M, Mayer EA, Chang L.

Am J Gastroenterol. 2005 Apr;100(4):896-904.

PMID:
15784038
19.

Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern.

Su AM, Shih W, Presson AP, Chang L.

Neurogastroenterol Motil. 2014 Jan;26(1):36-45. doi: 10.1111/nmo.12220.

20.

Effect of linaclotide on severe abdominal symptoms in patients with irritable bowel syndrome with constipation.

Rao SS, Quigley EM, Shiff SJ, Lavins BJ, Kurtz CB, MacDougall JE, Currie MG, Johnston JM.

Clin Gastroenterol Hepatol. 2014 Apr;12(4):616-23. doi: 10.1016/j.cgh.2013.09.022.

Supplemental Content

Support Center